Products

0.156 to 10ng/ml

1.56 to 100ng/ml

0.5 to 32ng/ml

0.5 to 32ng/ml

1.6-100 ng/ml

1.6-100 ng/ml

0.156 to 10ng/ml

Results exceeding CMLtoadduct level of 20 μg/mL CMLtoHSA should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the CMLtoHSA concentration.

Dilution factors need to be taken into consideration in calculating the Human CRP concentration. Results exceeding Human CRP level of 9.5 μg/ml should be repeated with diluted samples.

Dilution factors need to be taken into consideration in calculating the Adiponectin concentration. Results exceeding Adiponectin level of 32 μg/ml should be repeated with diluted samples.

62.5 - 4,000 pg/mL

62.5 pg/mL to 4,000 pg/mL

25 pg/mL to 1,600 pg/mL

400 - 6,400 pg/mL

0.188 ng/mL to 12 ng/ml

150 - 9,600 pg/mL

Results exceeding PCSK9 level of 1,000 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the PCSK9 concentration.

0.125 - 8 mAU/mL

Dilution factors need to be taken into consideration in calculating the Human RBP4 concentration. Results exceeding diluted Human RBP4 level of 100 ng/ml should be repeated with diluted samples.

100 - 6,400 pg/mL

Results exceeding human sRAGE level of 6.4 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the human sRAGE concentration.

0.188 ng/mL to 12 ng/mL

0.375 ng/mL to 24 ng/mL

37.5 pg/mL～24 ng/mL

Dilution factors need to be taken into consideration in calculating the human S100A7/Psoriasin concentration. Results exceeding human S100A7/Psoriasin level of 90 ng/ml should be repeated with diluted samples.

Dilution factors need to be taken into consideration in calculating the human S100A8/MRP8 concentration. Results exceeding human S100A8/MRP8 level of 500 ng/ml should be repeated with diluted samples.

Dilution factors need to be taken into consideration in calculating the human S100A9/MRP14 concentration. Results exceeding human S100A9/MRP14 level of 16 ng/ml should be repeated with diluted samples.

Results exceeding S100P level of 5 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the S100P concentration.

Dilution factors need to be taken into consideration in calculating the antitoCML antibody concentration. Results exceeding antitoCMLtoautoantibody level of 2000 ng/ml, the sample should be repeated with dilution buffer.

0.47 to 30ng/ml

102-25,000 pg/ml

102-25,000 pg/ml

47 to 3,000 pg/ml

47 to 3,000 pg/ml

0.001 - 5 µg/ml

0.001 - 5 µg/ml

102-25,000 pg/ml

102-25,000 pg/ml

0.25 to 16ng/ml